Adverse effects of COX-2 inhibitors: renal and arrhythmic events
Adverse effects of cyclooxygenase 2 inhibitors on renal and arrhythmia events: meta-analysis of randomized trials
JAMA 2006;296:1619-32 – Abstract and slides
Cardiovascular risk and cyclooxygenase inhibition
Cardiovascular risk and inhibition of cyclooxygenase: a systematic review of the observational studies of selective and nonselective inhibitors of cyclooxygenase 2
JAMA 2006;296:1633-44 – Abstract and slides
Celecoxib in the prevention of colorectal adenomatous polyps
Celecoxib for the prevention of sporadic colorectal adenomas
N Engl J Med 2006;355:873-84 – Abstract and slides
Celecoxib for the prevention of colorectal adenomatous polyps
N Engl J Med 2006;355:885-95 – Abstract and slides
——————————————————————————–
CONGRESSES
II SISA Provincial Conference – Pavia Section
Innovative aspects of therapy and their applications in cardiovascular disease
Pavia, 28 November 2006
Plan
Diagnosis and treatment of dyslipidemias: from clinical cases to guidelines
Milan, 1 December 2006
Brochure – Poster
Registration for the conference is free and is limited to the first 60 registrations
The patient at the center of the Health System: an innovative model for cardio-cerebrovascular prevention
Milan, 2 December 2006
Program – Registration form
Registration for the conference is free and is limited to the first 250 registrations
